Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
11
85%
Ph phase_4
1
8%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(11)
Other(1)

Detailed Status

Completed11
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 41 (7.7%)
N/A11 (84.6%)

Trials by Status

unknown18%
not_yet_recruiting18%
completed1185%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13